+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Aerie Pharmaceuticals - logo

Aerie Pharmaceuticals is a company that focuses on the development and commercialization of therapies for the treatment of glaucoma and other eye diseases. The National Eye Institute expects the number of people in the United States suffering from glaucoma to reach 4.3 million by 2030. Aerie was founded in 2005 and went in public in 2013, raising $67 million in its IPO. Its product candidates include Rhopressa and Roclatan. The company is headquartered in Irvine, California.

Macular Degeneration Treatment Global Market Report 2024 - Product Thumbnail Image

Macular Degeneration Treatment Global Market Report 2024

  • Report
  • February 2024
  • 200 Pages
  • Global
From
From
From
Optic Nerve Disorders Treatment Global Market Report 2024 - Product Thumbnail Image

Optic Nerve Disorders Treatment Global Market Report 2024

  • Report
  • January 2024
  • 175 Pages
  • Global
From
Ophthalmic Drugs Global Market Report 2024 - Product Thumbnail Image

Ophthalmic Drugs Global Market Report 2024

  • Report
  • January 2024
  • 200 Pages
  • Global
From
Ocular Hypertension Treatment Global Market Report 2024 - Product Thumbnail Image

Ocular Hypertension Treatment Global Market Report 2024

  • Report
  • January 2024
  • 200 Pages
  • Global
From
Antiglaucoma Drugs Global Market Report 2024 - Product Thumbnail Image

Antiglaucoma Drugs Global Market Report 2024

  • Report
  • November 2023
  • 175 Pages
  • Global
From
From
From
From
From
From
From
Glaucoma Therapeutics Market Report and Forecast 2023-2031 - Product Thumbnail Image

Glaucoma Therapeutics Market Report and Forecast 2023-2031

  • Report
  • May 2023
  • 160 Pages
  • Global
From
Proliferative Diabetic Retinopathy (PDR) - Pipeline Review, H2 2020 - Product Thumbnail Image

Proliferative Diabetic Retinopathy (PDR) - Pipeline Review, H2 2020

  • Drug Pipelines
  • September 2020
  • 57 Pages
  • Global
From
Corneal Endothelial Dystrophy - Pipeline Insight, 2024 - Product Thumbnail Image

Corneal Endothelial Dystrophy - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 40 Pages
  • Global
From
Loading Indicator